Merck sells Brazilian clinical chemistry business to Bayer
This article was originally published in Clinica
Executive Summary
Merck is quitting the clinical chemistry business in the burgeoning Brazilian market and is selling out to Bayer Diagnostics, which now becomes brand leader in the region.